ProductDescription
LY2886721isanorally-available,furothiazine-basedinhibitorofb-amyloidproteincleavingenzyme(BACE)forthetreatmentofAlzheimer"sdisease.[1]ItinhibitsrecombinanthBACE1withanIC50of20nM.[2]Incellularassays,LY2886721inhibitsAbetawithanIC50rangeof10-19nM.OraladmiNISTrationofLY2886721toPDAPPmiceproduceddose-dependentreductionsinbrainAbeta,C99,andsAPPbeta.[2]
Technicalinformation:
ChemicalFormula: | C18H16F2N4O2S | |
CAS#: | 1262036-50-9 | |
MolecularWeight: | 390.41 | |
Purity: | >98% | |
Appearance: | White | |
ChemicalName: | N-(3-((4aS,7aS)-2-amino-4a,5,7,7a-tetrahydro-4H-furo[3,4-d][1,3]thiazin-7a-yl)-4-fluorophenyl)-5-fluoropicolinamide | |
Solubility: | Upto20mMinDMSO | |
Synonyms: | LY-2886721,LY2886721,LY2886721 |
ShippingCondition:Theproductisshippedinaglassvialatambienttemperature.
Storagecondition:Forlongershelflife,storesolidpowderat4oCdesiccated,orstoreDMSOsolutionat-20oC.
Reference:
1. | Alzheimer"sDiseaseResearchUnitStudiessynopsis(April1,2012) |
2. | AlzheimerAssocationInternationalConference,2012,OralSessions(O1-06-03):"PreclinicalCharacterizationofLY2886721:ABACE1inhibitorinclinicaldevelopmetnforearlyAlzheimer"sdisease" |
Cellagen的ChamQ SYBR qPCR预混液(无ROX)| Q321产品描述ChamQSYBR®qPCR预混液(Vazyme,#Q321)由香槟Taq DNA聚合酶(Vazyme,#P122)通过抗体修饰的热启动激活技术保护,是专为基于SYBR Green I的定量PCR(qPCR)设计的。ChamQSYBR®qPCR Master Mix的优化缓冲液系统中的独特因素(即促进特异性的Exactor)大大提高了其灵敏度和特异性。该混合物以2倍反应浓度制备,可直接用于鲁棒性低模板qPCR,具有高灵敏度,特异性和可靠性。优点特异性+敏感性的最佳组合。独特的抗体修饰的热启动taq,具有独特的特异性促进因子。Mg2 +和染料的最佳浓度。